Astrocytic CCAAT/Enhancer Binding Protein δ Regulates Neuronal Viability and Spatial Learning Ability via miR-135a

Yu Yi Chu, Chiung Yuan Ko, Wei Jan Wang, Shao Ming Wang, Po Wu Gean, Yu Min Kuo, Ju Ming Wang

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The progression of Alzheimer’s disease (AD) has been associated with astrocytes-induced neuroinflammation. However, the detailed mechanism of astrocytes associated with learning impairments and neuronal loss in AD is poorly defined. Here, we provide novel evidences that astrocytic miR-135a is critical for neuronal viability and spatial learning ability in vivo. The AppTg/Cebpd−/− mice showed a spatial learning improvement compared with the APPswe/PS1/E9 bigenic (AppTg) mice. miR-135a was found to be a CCAAT/enhancer binding protein δ (CEBPD) responsive miRNA and can repress the transcription of thrombospondin 1 (THBS1) / Thbs1 (mouse) via its 3′-untranslated region (3′UTR). We used different experimental approaches to attenuate the expression of CEBPD/Cebpd (mouse) or miR-135a in astrocytes and found the following results: increase in THBS1/Thbs1 expression, decrease in neuronal apoptosis, and increase in growth of neurites. Importantly, injection of miR-135a antagonist (AM135a) into the brain of AppTg mice was found to prevent neuronal apoptosis and improved the spatial learning ability. Together, our findings demonstrate a critical function for the astrocytic CEBPD, and point to miR-135a antagonist as an attractive therapeutic target for the treatment of Alzheimer’s disease.

Original languageEnglish
JournalMolecular Neurobiology
DOIs
Publication statusPublished - 2016

Fingerprint

CCAAT-Enhancer-Binding Proteins
Astrocytes
Alzheimer Disease
Apoptosis
Thrombospondin 1
3' Untranslated Regions
Neurites
MicroRNAs
Learning
Injections
Brain
Therapeutics
Growth
Spatial Navigation
Spatial Learning

Keywords

  • miR-135a
  • Neuroinflammation
  • Neuronal viability
  • Neuroprotective factor
  • Spatial learning ability

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience

Cite this

Astrocytic CCAAT/Enhancer Binding Protein δ Regulates Neuronal Viability and Spatial Learning Ability via miR-135a. / Chu, Yu Yi; Ko, Chiung Yuan; Wang, Wei Jan; Wang, Shao Ming; Gean, Po Wu; Kuo, Yu Min; Wang, Ju Ming.

In: Molecular Neurobiology, 2016.

Research output: Contribution to journalArticle

Chu, Yu Yi ; Ko, Chiung Yuan ; Wang, Wei Jan ; Wang, Shao Ming ; Gean, Po Wu ; Kuo, Yu Min ; Wang, Ju Ming. / Astrocytic CCAAT/Enhancer Binding Protein δ Regulates Neuronal Viability and Spatial Learning Ability via miR-135a. In: Molecular Neurobiology. 2016.
@article{4d5d194b685b41e78f05546d28e37fb0,
title = "Astrocytic CCAAT/Enhancer Binding Protein δ Regulates Neuronal Viability and Spatial Learning Ability via miR-135a",
abstract = "The progression of Alzheimer’s disease (AD) has been associated with astrocytes-induced neuroinflammation. However, the detailed mechanism of astrocytes associated with learning impairments and neuronal loss in AD is poorly defined. Here, we provide novel evidences that astrocytic miR-135a is critical for neuronal viability and spatial learning ability in vivo. The AppTg/Cebpd−/− mice showed a spatial learning improvement compared with the APPswe/PS1/E9 bigenic (AppTg) mice. miR-135a was found to be a CCAAT/enhancer binding protein δ (CEBPD) responsive miRNA and can repress the transcription of thrombospondin 1 (THBS1) / Thbs1 (mouse) via its 3′-untranslated region (3′UTR). We used different experimental approaches to attenuate the expression of CEBPD/Cebpd (mouse) or miR-135a in astrocytes and found the following results: increase in THBS1/Thbs1 expression, decrease in neuronal apoptosis, and increase in growth of neurites. Importantly, injection of miR-135a antagonist (AM135a) into the brain of AppTg mice was found to prevent neuronal apoptosis and improved the spatial learning ability. Together, our findings demonstrate a critical function for the astrocytic CEBPD, and point to miR-135a antagonist as an attractive therapeutic target for the treatment of Alzheimer’s disease.",
keywords = "miR-135a, Neuroinflammation, Neuronal viability, Neuroprotective factor, Spatial learning ability",
author = "Chu, {Yu Yi} and Ko, {Chiung Yuan} and Wang, {Wei Jan} and Wang, {Shao Ming} and Gean, {Po Wu} and Kuo, {Yu Min} and Wang, {Ju Ming}",
year = "2016",
doi = "10.1007/s12035-015-9359-z",
language = "English",
journal = "Molecular Neurobiology",
issn = "0893-7648",
publisher = "Humana Press",

}

TY - JOUR

T1 - Astrocytic CCAAT/Enhancer Binding Protein δ Regulates Neuronal Viability and Spatial Learning Ability via miR-135a

AU - Chu, Yu Yi

AU - Ko, Chiung Yuan

AU - Wang, Wei Jan

AU - Wang, Shao Ming

AU - Gean, Po Wu

AU - Kuo, Yu Min

AU - Wang, Ju Ming

PY - 2016

Y1 - 2016

N2 - The progression of Alzheimer’s disease (AD) has been associated with astrocytes-induced neuroinflammation. However, the detailed mechanism of astrocytes associated with learning impairments and neuronal loss in AD is poorly defined. Here, we provide novel evidences that astrocytic miR-135a is critical for neuronal viability and spatial learning ability in vivo. The AppTg/Cebpd−/− mice showed a spatial learning improvement compared with the APPswe/PS1/E9 bigenic (AppTg) mice. miR-135a was found to be a CCAAT/enhancer binding protein δ (CEBPD) responsive miRNA and can repress the transcription of thrombospondin 1 (THBS1) / Thbs1 (mouse) via its 3′-untranslated region (3′UTR). We used different experimental approaches to attenuate the expression of CEBPD/Cebpd (mouse) or miR-135a in astrocytes and found the following results: increase in THBS1/Thbs1 expression, decrease in neuronal apoptosis, and increase in growth of neurites. Importantly, injection of miR-135a antagonist (AM135a) into the brain of AppTg mice was found to prevent neuronal apoptosis and improved the spatial learning ability. Together, our findings demonstrate a critical function for the astrocytic CEBPD, and point to miR-135a antagonist as an attractive therapeutic target for the treatment of Alzheimer’s disease.

AB - The progression of Alzheimer’s disease (AD) has been associated with astrocytes-induced neuroinflammation. However, the detailed mechanism of astrocytes associated with learning impairments and neuronal loss in AD is poorly defined. Here, we provide novel evidences that astrocytic miR-135a is critical for neuronal viability and spatial learning ability in vivo. The AppTg/Cebpd−/− mice showed a spatial learning improvement compared with the APPswe/PS1/E9 bigenic (AppTg) mice. miR-135a was found to be a CCAAT/enhancer binding protein δ (CEBPD) responsive miRNA and can repress the transcription of thrombospondin 1 (THBS1) / Thbs1 (mouse) via its 3′-untranslated region (3′UTR). We used different experimental approaches to attenuate the expression of CEBPD/Cebpd (mouse) or miR-135a in astrocytes and found the following results: increase in THBS1/Thbs1 expression, decrease in neuronal apoptosis, and increase in growth of neurites. Importantly, injection of miR-135a antagonist (AM135a) into the brain of AppTg mice was found to prevent neuronal apoptosis and improved the spatial learning ability. Together, our findings demonstrate a critical function for the astrocytic CEBPD, and point to miR-135a antagonist as an attractive therapeutic target for the treatment of Alzheimer’s disease.

KW - miR-135a

KW - Neuroinflammation

KW - Neuronal viability

KW - Neuroprotective factor

KW - Spatial learning ability

UR - http://www.scopus.com/inward/record.url?scp=84937908174&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937908174&partnerID=8YFLogxK

U2 - 10.1007/s12035-015-9359-z

DO - 10.1007/s12035-015-9359-z

M3 - Article

C2 - 26208701

AN - SCOPUS:84937908174

JO - Molecular Neurobiology

JF - Molecular Neurobiology

SN - 0893-7648

ER -